
Retinoblastoma (Rb), a potentially deadly eye cancer affecting children up to age five, is highly curable in high-income countries.
But in many other countries, barriers to healthcare cause survival rates to plummet below 50 percent.

Retinoblastoma (Rb), a potentially deadly eye cancer affecting children up to age five, is highly curable in high-income countries.
But in many other countries, barriers to healthcare cause survival rates to plummet below 50 percent.